Filtered By:
Specialty: International Medicine & Public Health
Countries: Scotland Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 3 results found since Jan 2013.

Let Plants be Thy Medicine – You Are What You Eat
Credit: Busani Bafana/IPSBy Esther Ngumbi and Ifeanyi NsoforILLINOIS, United States / ABUJA, Oct 16 2019 (IPS) United Nations World Food Day is celebrated around the world on October 16 under the theme: “Our Actions ARE Our Future. Healthy Diets for a Zero Hunger World”. This theme is timely, especially, because across Africa and around the world, there has been a gradual rise in malnutrition and diet-related non communicable diseases, as highlighted in The Lancet study and a United Nations Report published earlier this year. While 45 percent of deaths in children are from nutrition-related causes, mainly malnu...
Source: IPS Inter Press Service - Health - October 16, 2019 Category: International Medicine & Public Health Authors: Esther Ngumbi and Ifeanyi Nsofor Tags: Food & Agriculture Global Headlines Health World Food Day Source Type: news

Researchers map brain of blind patient who can see motion
(University of Western Ontario) Since the visual processing centres of her brain went dark after a stroke, a Scottish woman has been unable to see objects. However, she has developed the remarkable ability to see objects in motion, neuroscientists at Western University in Canada have discovered.
Source: EurekAlert! - Medicine and Health - June 12, 2018 Category: International Medicine & Public Health Source Type: news

Nuedexta for the Treatment of Pseudobulbar Affect: Estimating the Financial Impact to the Scottish NHS
Pseudobulbar Affect (PBA) is a neurologic disorder of emotional expression, resulting in frequent and involuntary episodes of crying and/or laughing. Common neurological conditions associated with PBA include: Alzheimer’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson’s disease, stroke and traumatic brain injury. Nuedexta® (Avanir Pharmaceuticals Inc. ) is the only EMA-approved PBA treatment. The financial impact of introducing Nuedexta to a national health care system, including Scotland, has never been formally estimated.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: C. Kiff, S. Mealing, M. Singh, S. Baculea, A. Badhan, C. Yonan Source Type: research